AZ to appeal$215M Alabama judgment

A jury hit AstraZeneca with $215 million in damages as paybacks for overcharging the state of Alabama for drugs for 15 years. And AstraZeneca is just the first of 70 drug makers to go to trial. In 2005, Attorney General Troy King sued scores of pharma companies over Medicaid prices, and has settled with only two--Dey and Takeda Pharmaceuticals--which agreed to pay $6.75 million.

AstraZeneca says it's appealing the decision posthaste. The court allowed evidence from earlier pricing settlements "in clear violation of the rules of evidence," the company says. Plus, AstraZeneca claims, trial lawyers and state officials prejudiced potential jurors by making "negative public comments" before jury selection.

- check out AstraZeneca's release
- read this report
- see the item at Pharmalot

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.